Science Source January 20, 2009 DVD
EN_00957889_0223
Bottles containing the anti-HIV medication T-1249 developed by the Trimeris Biopharmaceutical Company. T-1249 is in a category of HIV medicines called fusion inhibitors, or entry inhibitors. Entry inhibitors are a new class of anti-HIV drugs none of which have yet been approved for the treatment of HIV. T-1249 binds to a protein on HIV's surface called gp41. Once this occurs, HIV cannot bind with the surface of T-cells, thus preventing the virus from infecting healthy cells.
2011-03-21
EAST NEWS
Science Source
Will & Deni McIntyre
3v6479
0,76MB
24cm x 16cm by 300dpi
A, ACQUIRED, ANTI-HIV, APPROVED, ARE, BEEN, BIALKO, BIALKOWA, BIALKOWE, BIALKOWY, BIND, BINDS, BIOPHARMACEUTICAL, BOTTLES, BUTELKI, BY, CALLED, CANNOT, CATEGORY, CELLS, CLASS, COMPANY, CONTAINING, CZLOWIEK, DEFICIENCY, DENI, DEVELOPED, DRUG, DRUGS, ENTRY, FIRMA, FOR, FROM, FUSION, GP41, HAVE, HEALTHY, HIV, HORIZONTAL, HUMAN, IMMUNE, IMMUNODEFICIENCY, IN, INFECTING, INHIBITOR, INHIBITORS, IS, KLASA, KOMORKI, KOMORKOWE, LACZENIE, LACZYC, LEK, LEKARSTWA, LEKARSTWO, LEKI, MCINTYRE, MEDICATION, MEDICATIONS, MEDICINES, NARKOTYK, NARKOTYKI, NARKOTYZOWAC, NEW, NONE, NOWA, NOWE, NOWY, OCCURS, OF, ON, ONCE, OR, POWIERZCHNIA, POZIOMA, POZIOME, POZIOMY, PREVENTING, PROTEIN, PROTEINA, PROTEINOWA, PROTEINOWE, PROTEINOWY, PRZYWIAZYWAC, PRZYWIAZYWANIE, SURFACE, SYNDROME, T-CELLS, TELEFONY, TESTAMENT, THE, THIS, THUS, TO, TREATMENT, TRIMERIS, VIRUS, W, WHICH, WIAZAC, WIAZANIE, WILL, WITH, YET, Z, ZABIEG, ZAWIERAJACA, ZAWIERAJACE, ZAWIERAJACY, ZDROWA, ZDROWE, ZDROWY, ZWIAZAC, ZWIAZYWANIE,